Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iodine-131 Anti-B1 Antibody plus CHOP in untreated mantle cell lymphoma
NCT00022945Phase 2Completed
- Sponsor
- Corixa Corporation
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of 131-iodine tositumomab in mantle cell lymphoma (MCL), sponsored by Corixa Corporation. Status: completed.
02
Drugs
131-iodine tositumomab
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT00022945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00022945.